These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 21735667)
1. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck]. Golusinski P; Lamperska K; Pazdrowski J; Golusinski W Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667 [TBL] [Abstract][Full Text] [Related]
2. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417 [TBL] [Abstract][Full Text] [Related]
3. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376 [TBL] [Abstract][Full Text] [Related]
4. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114 [TBL] [Abstract][Full Text] [Related]
5. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy. Ganly I; Soutar DS; Brown R; Kaye SB Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894 [TBL] [Abstract][Full Text] [Related]
6. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma. Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352 [TBL] [Abstract][Full Text] [Related]
7. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378 [TBL] [Abstract][Full Text] [Related]
8. p53 mutations in human head and neck cancer cell lines. Kiuru A; Servomaa K; Grénman R; Pulkkinen J; Rytömaa T Acta Otolaryngol Suppl; 1997; 529():237-40. PubMed ID: 9288320 [TBL] [Abstract][Full Text] [Related]
9. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641 [TBL] [Abstract][Full Text] [Related]
10. TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck. Alsner J; Sørensen SB; Overgaard J Radiother Oncol; 2001 May; 59(2):179-85. PubMed ID: 11325447 [TBL] [Abstract][Full Text] [Related]
11. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. Olshan AF; Weissler MC; Pei H; Conway K Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336 [TBL] [Abstract][Full Text] [Related]
12. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study. Peltonen JK; Vähäkangas KH; Helppi HM; Bloigu R; Pääkkö P; Turpeenniemi-Hujanen T Head Neck Oncol; 2011 Apr; 3():20. PubMed ID: 21513535 [TBL] [Abstract][Full Text] [Related]
13. Frequent p53 mutations in head and neck cancer. Somers KD; Merrick MA; Lopez ME; Incognito LS; Schechter GL; Casey G Cancer Res; 1992 Nov; 52(21):5997-6000. PubMed ID: 1394225 [TBL] [Abstract][Full Text] [Related]
14. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck. Alsner J; Høyer M; Sørensen SB; Overgaard J Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149 [TBL] [Abstract][Full Text] [Related]
15. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303 [TBL] [Abstract][Full Text] [Related]
16. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Schneider-Stock R; Mawrin C; Motsch C; Boltze C; Peters B; Hartig R; Buhtz P; Giers A; Rohrbeck A; Freigang B; Roessner A Am J Pathol; 2004 Apr; 164(4):1233-41. PubMed ID: 15039212 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. Riedel F; Götte K; Schwalb J; Schäfer C; Hörmann K Acta Otolaryngol; 2000 Jan; 120(1):105-11. PubMed ID: 10779196 [TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217 [TBL] [Abstract][Full Text] [Related]
19. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck. Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018 [TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]